Formulation and In Vitro Evaluation of Doxophylline Oral Disintegrating Tablets
[...]in this investigation an attempt was made to develop oral disintegrating tablets of Doxofylline with super disintegrating agents like Sodium starch glycolate (SSG), Crospovidone and Ac-Di-Sol. The disintegration time for ODTs generally ranges from several seconds to about a minute.3'4 5 Th...
Gespeichert in:
| Veröffentlicht in: | Research journal of pharmacy and technology 2020, Vol.13 (6), p.2811-2814 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2814 |
|---|---|
| container_issue | 6 |
| container_start_page | 2811 |
| container_title | Research journal of pharmacy and technology |
| container_volume | 13 |
| creator | Reddy, Y. Krishna Ahmed, Syed Suhaib |
| description | [...]in this investigation an attempt was made to develop oral disintegrating tablets of Doxofylline with super disintegrating agents like Sodium starch glycolate (SSG), Crospovidone and Ac-Di-Sol. The disintegration time for ODTs generally ranges from several seconds to about a minute.3'4 5 The ideal characteristics of a drug for oral dispersible tablet include * Ability to permeate the oral mucosa. * Very bitter or unacceptable taste and odor drugs are unsuitable for ODT6 Desired criteria for ODTs: * ODT should leave minimal or no residue in mouth after oral administration, compatible with pleasing mouth feel. * Be portable and without fragility concern.7,8 MATERIALS: [...]concluded that F6 Formulation (containing Crospovidone) was optimized better formulation. |
| doi_str_mv | 10.5958/0974-360X.2020.00500.4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2435546634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2435546634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c145t-cd6af0541437d98d3af2c1f32f84c0af9ec98adec9b3c1a02964f51cb14f49e53</originalsourceid><addsrcrecordid>eNo9kEtLAzEQgIMoWGr_ggQ875rnNjlKH1oo9FLFW0izSd2SJjXZFf337lrpHGaGmY8Z-AC4x6jkkotHJKesoBV6LwkiqESII1SyKzC6LK4vPRa3YJLzAfVRCU6YGIHNMqZj53XbxAB1qOEqwLemTREuvrTvzvPo4Dx-x9PHj_dNsHCTtIfzJjehtfvUM2EPt3rnbZvvwI3TPtvJfx2D1-ViO3sp1pvn1expXRjMeFuYutIOcYYZndZS1FQ7YrCjxAlmkHbSGil03ecdNVgjIivmODY7zByTltMxeDjfPaX42dncqkPsUuhfKsIo56yqKOup6kyZFHNO1qlTao46_SiM1OBPDWrUoEkN_tSfP8XoL1R8Y-s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435546634</pqid></control><display><type>article</type><title>Formulation and In Vitro Evaluation of Doxophylline Oral Disintegrating Tablets</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Reddy, Y. Krishna ; Ahmed, Syed Suhaib</creator><creatorcontrib>Reddy, Y. Krishna ; Ahmed, Syed Suhaib</creatorcontrib><description>[...]in this investigation an attempt was made to develop oral disintegrating tablets of Doxofylline with super disintegrating agents like Sodium starch glycolate (SSG), Crospovidone and Ac-Di-Sol. The disintegration time for ODTs generally ranges from several seconds to about a minute.3'4 5 The ideal characteristics of a drug for oral dispersible tablet include * Ability to permeate the oral mucosa. * Very bitter or unacceptable taste and odor drugs are unsuitable for ODT6 Desired criteria for ODTs: * ODT should leave minimal or no residue in mouth after oral administration, compatible with pleasing mouth feel. * Be portable and without fragility concern.7,8 MATERIALS: [...]concluded that F6 Formulation (containing Crospovidone) was optimized better formulation.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2020.00500.4</identifier><language>eng</language><publisher>Raipur: A&V Publications</publisher><subject>Chronic obstructive pulmonary disease ; Drug delivery systems ; Drug dosages ; Dysphagia ; Pharmaceuticals ; Pharmacy ; Sodium</subject><ispartof>Research journal of pharmacy and technology, 2020, Vol.13 (6), p.2811-2814</ispartof><rights>Copyright A&V Publications Jun 2020</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids></links><search><creatorcontrib>Reddy, Y. Krishna</creatorcontrib><creatorcontrib>Ahmed, Syed Suhaib</creatorcontrib><title>Formulation and In Vitro Evaluation of Doxophylline Oral Disintegrating Tablets</title><title>Research journal of pharmacy and technology</title><description>[...]in this investigation an attempt was made to develop oral disintegrating tablets of Doxofylline with super disintegrating agents like Sodium starch glycolate (SSG), Crospovidone and Ac-Di-Sol. The disintegration time for ODTs generally ranges from several seconds to about a minute.3'4 5 The ideal characteristics of a drug for oral dispersible tablet include * Ability to permeate the oral mucosa. * Very bitter or unacceptable taste and odor drugs are unsuitable for ODT6 Desired criteria for ODTs: * ODT should leave minimal or no residue in mouth after oral administration, compatible with pleasing mouth feel. * Be portable and without fragility concern.7,8 MATERIALS: [...]concluded that F6 Formulation (containing Crospovidone) was optimized better formulation.</description><subject>Chronic obstructive pulmonary disease</subject><subject>Drug delivery systems</subject><subject>Drug dosages</subject><subject>Dysphagia</subject><subject>Pharmaceuticals</subject><subject>Pharmacy</subject><subject>Sodium</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kEtLAzEQgIMoWGr_ggQ875rnNjlKH1oo9FLFW0izSd2SJjXZFf337lrpHGaGmY8Z-AC4x6jkkotHJKesoBV6LwkiqESII1SyKzC6LK4vPRa3YJLzAfVRCU6YGIHNMqZj53XbxAB1qOEqwLemTREuvrTvzvPo4Dx-x9PHj_dNsHCTtIfzJjehtfvUM2EPt3rnbZvvwI3TPtvJfx2D1-ViO3sp1pvn1expXRjMeFuYutIOcYYZndZS1FQ7YrCjxAlmkHbSGil03ecdNVgjIivmODY7zByTltMxeDjfPaX42dncqkPsUuhfKsIo56yqKOup6kyZFHNO1qlTao46_SiM1OBPDWrUoEkN_tSfP8XoL1R8Y-s</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Reddy, Y. Krishna</creator><creator>Ahmed, Syed Suhaib</creator><general>A&V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2020</creationdate><title>Formulation and In Vitro Evaluation of Doxophylline Oral Disintegrating Tablets</title><author>Reddy, Y. Krishna ; Ahmed, Syed Suhaib</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c145t-cd6af0541437d98d3af2c1f32f84c0af9ec98adec9b3c1a02964f51cb14f49e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Chronic obstructive pulmonary disease</topic><topic>Drug delivery systems</topic><topic>Drug dosages</topic><topic>Dysphagia</topic><topic>Pharmaceuticals</topic><topic>Pharmacy</topic><topic>Sodium</topic><toplevel>online_resources</toplevel><creatorcontrib>Reddy, Y. Krishna</creatorcontrib><creatorcontrib>Ahmed, Syed Suhaib</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reddy, Y. Krishna</au><au>Ahmed, Syed Suhaib</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulation and In Vitro Evaluation of Doxophylline Oral Disintegrating Tablets</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2020</date><risdate>2020</risdate><volume>13</volume><issue>6</issue><spage>2811</spage><epage>2814</epage><pages>2811-2814</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[...]in this investigation an attempt was made to develop oral disintegrating tablets of Doxofylline with super disintegrating agents like Sodium starch glycolate (SSG), Crospovidone and Ac-Di-Sol. The disintegration time for ODTs generally ranges from several seconds to about a minute.3'4 5 The ideal characteristics of a drug for oral dispersible tablet include * Ability to permeate the oral mucosa. * Very bitter or unacceptable taste and odor drugs are unsuitable for ODT6 Desired criteria for ODTs: * ODT should leave minimal or no residue in mouth after oral administration, compatible with pleasing mouth feel. * Be portable and without fragility concern.7,8 MATERIALS: [...]concluded that F6 Formulation (containing Crospovidone) was optimized better formulation.</abstract><cop>Raipur</cop><pub>A&V Publications</pub><doi>10.5958/0974-360X.2020.00500.4</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0974-3618 |
| ispartof | Research journal of pharmacy and technology, 2020, Vol.13 (6), p.2811-2814 |
| issn | 0974-3618 0974-360X 0974-306X |
| language | eng |
| recordid | cdi_proquest_journals_2435546634 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Chronic obstructive pulmonary disease Drug delivery systems Drug dosages Dysphagia Pharmaceuticals Pharmacy Sodium |
| title | Formulation and In Vitro Evaluation of Doxophylline Oral Disintegrating Tablets |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A34%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulation%20and%20In%20Vitro%20Evaluation%20of%20Doxophylline%20Oral%20Disintegrating%20Tablets&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Reddy,%20Y.%20Krishna&rft.date=2020&rft.volume=13&rft.issue=6&rft.spage=2811&rft.epage=2814&rft.pages=2811-2814&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2020.00500.4&rft_dat=%3Cproquest_cross%3E2435546634%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2435546634&rft_id=info:pmid/&rfr_iscdi=true |